|
|
||||||||
/ Mice1


* Department for Medical Genetics, Molecular and Clinical Pharmacology, Medical University, Innsbruck, Austria; and
Department of Experimental Endocrinology, Medical University, Hanover, Germany
Using model tumor T cell lines, protein kinase C (PKC)
has been implicated in IL-2 cytokine promoter activation in response to Ag receptor stimulation. In this study, for the first time, PKC
null mutant mice are analyzed and display normal T and B lymphocyte development. Peripheral CD3+ PKC
-deficient T cells show unimpaired activation-induced IL-2 cytokine secretion, surface expression of CD25, CD44, and CD69, as well as transactivation of the critical transcription factors NF-AT, NF-
B, AP-1, and STAT5 in vitro. Nevertheless, CD3/CD28 Ab- and MHC alloantigen-induced T cell proliferation and IFN-
production are severely impaired in PKC
/ CD3+ T cells. Consistently, PKC
-deficient CD3+ T cells from OVA-immunized PKC
-deficient mice exhibit markedly reduced recall proliferation to OVA in in vitro cultures. In vivo, PKC
-deficient mice give diminished OVA-specific IgG2a and IgG2b responses following OVA immunization experiments. In contrast, OVA-specific IgM and IgG1 responses and splenic PKC
/ B cell proliferation are unimpaired. Our genetic data, thus, define PKC
as the physiological and nonredundant PKC isotype in signaling pathways that are necessary for T cell-dependent IFN-
production and IgG2a/2b Ab responses.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |